Publications by authors named "Kathy Weitung Lin"

Claim this Profile
N
Neutralising antibody responses against SARS-CoV-2 Omicron BA.4/5 and wild-type virus in patients with inflammatory bowel disease following three doses of COVID-19 vaccine (VIP): a prospective, multicentre, cohort study.
Zhigang Liu, James L Alexander, Kaixing Le, Xin Zhou, Hajir Ibraheim, Kathy Weitung Lin, Rachel Linger

EClinicalMedicine· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infliximab and Tofacitinib Attenuate Neutralizing Antibody Responses Against SARS-CoV-2 Ancestral and Omicron Variants in Inflammatory Bowel Disease Patients After 3 Doses of COVID-19 Vaccine.
Zhigang Liu, James L Alexander, Kathy Weitung Lin, , Tariq Ahmad

Gastroenterology· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis